FindTrial
Sign In

Efficacy and efficacy influencing factors of 131I in the treatment of GD patients with macrothyroid

Efficacy and efficacy influencing factors of 131I in the treatment of GD patients with macrothyroid: a case-control study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500101792
Enrollment
Unknown
Registered
2025-04-29
Start date
2025-05-01
Completion date
Unknown
Last updated
2025-05-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Graves Disease

Interventions

Observation group:None

Sponsors

The First Affiliated Hospital of Nanchang University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Meet the diagnostic criteria for GD and giant goiter at the same time; 2.Complete pre-treatment data and regular follow-up after treatment; 3.There are no contraindications to radioactive iodine treatment.

Exclusion criteria

Exclusion criteria: 1.Female patients who are pregnant or lactating, or those planning to become pregnant within 4-6 months; 2.Patients who have previously undergone thyroidectomy or 131I treatment; 3.Patients diagnosed with or suspected of having thyroid cancer; 4.Patients lost to follow-up or with incomplete clinical data.

Design outcomes

Primary

MeasureTime frame
Thyroid Function Panel;—

Countries

China

Contacts

Public ContactQing Zhang

The First Affiliated Hospital of Nanchang University

10187476@qq.com+86 791 8890889

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026